This article's titular declaration that the "US is not ready for bird flu in humans" is myopic. We beg to differ from this opinion, and hereby declare that our broad-spectrum antiviral drug NV-387 ...

New water-soluble galectin antagonist being considered in preclinical trials offering hope for rapid containment to H5N1 outbreaksBOSTON, ...

A woman in Wyoming and a farm worker in Ohio marked the latest Americans hospitalized with bird flu, as the virus continues ... the Food and Drug Administration and the National Institutes of ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...